Chapter 1 Antipsychotic Agents
- 1 January 1987
- book chapter
- Published by Elsevier
- Vol. 22, 1-10
- https://doi.org/10.1016/s0065-7743(08)61149-5
Abstract
No abstract availableThis publication has 88 references indexed in Scilit:
- (+)-3-(3-Hydroxyphenyl)-N-(1-propyl)piperidine [(+)-3-PPP] but not (-)-3-PPP produces (+)-N-Allynormetazocine-like (SKF 10,047) discriminative stimuliLife Sciences, 1986
- Acute and subchronic effects of Rimcazole (BW 234U), a potential antipsychotic drug, on A9 and A10 dopamine neurons in the ratLife Sciences, 1986
- CGS 10746B: An atypical antipsychotic candidate that selectively decreases dopamine release at behaviorally effective dosesLife Sciences, 1986
- Fluperlapine: A Therapeutic Alternative in Schizophrenic PsychosesPharmacopsychiatry, 1986
- Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brainLife Sciences, 1986
- Specific binding of 3H-SCH 23390 to dopamine D1 receptorsLife Sciences, 1986
- SCH23390 causes persistent antidopaminergic effects in vivo: Evidence for longterm occupation of receptorsLife Sciences, 1985
- Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonistLife Sciences, 1985
- Preparation of 11C-labelled raclopride, a new potent dopamine receptor antagonist: Preliminary PET studies of cerebral dopamine receptors in the monkeyThe International Journal of Applied Radiation and Isotopes, 1985
- A10 dopamine neurons: Role of autoreceptors in determining firing rate and sensitivity to dopamine agonistsLife Sciences, 1984